Cargando…

MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1

Detalles Bibliográficos
Autores principales:	Flaum, Nicola, Crosbie, Emma J, Woodward, Emma Roisin, Lalloo, Fiona, Morgan, Robert, Ryan, Neil, Evans, D Gareth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Cancer Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313943/ https://www.ncbi.nlm.nih.gov/pubmed/36894311 http://dx.doi.org/10.1136/jmg-2022-109055

Ejemplares similares

Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels
por: Crosbie, Emma J., et al.
Publicado: (2020)

Assessment of mismatch repair deficiency in ovarian cancer
por: Crosbie, Emma J, et al.
Publicado: (2021)

High likelihood of actionable pathogenic variant detection in breast cancer genes in women with very early onset breast cancer
por: Evans, D Gareth, et al.
Publicado: (2022)

The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2
por: Philpott, Sue, et al.
Publicado: (2023)

Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancers
por: Evans, D Gareth, et al.
Publicado: (2022)

Is Reflex Germline BRCA1/2 Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?
por: Morgan, Robert D., et al.
Publicado: (2023)

BRCA1 and BRCA2 pathogenic variant carriers and endometrial cancer risk: A cohort study
por: Kitson, Sarah J., et al.
Publicado: (2020)

Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family
por: Evans, D Gareth, et al.
Publicado: (2008)

Association between genetic polymorphisms and endometrial cancer risk: a systematic review
por: Bafligil, Cemsel, et al.
Publicado: (2020)

New paradigms for BRCA1/BRCA2 testing in women with ovarian cancer: results of the Genetic Testing in Epithelial Ovarian Cancer (GTEOC) study
por: Plaskocinska, Inga, et al.
Publicado: (2016)

Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies
por: Ryan, Neil A. J., et al.
Publicado: (2017)

Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in BRCA1, BRCA2, and TP53 Genes in Women with Very Early-Onset (<36 Years) Breast Cancer
por: Hyder, Zerin, et al.
Publicado: (2020)

Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers
por: Antoniou, Antonis C, et al.
Publicado: (2006)

A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects
por: Jervis, Sarah, et al.
Publicado: (2015)

BRCA and lynch syndrome-associated ovarian cancers behave differently
por: Ryan, Neil A.J., et al.
Publicado: (2017)

Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study
por: Gaba, Faiza, et al.
Publicado: (2022)

Cancer Variant Interpretation Group UK (CanVIG-UK): an exemplar national subspecialty multidisciplinary network
por: Garrett, Alice, et al.
Publicado: (2020)

Germline truncating mutations in both MSH2 and BRCA2 in a single kindred
por: Thiffault, I, et al.
Publicado: (2004)

30 year experience of index case identification and outcomes of cascade testing in high-risk breast and colorectal cancer predisposition genes
por: Woodward, Emma R., et al.
Publicado: (2021)

Young age at first pregnancy does protect against early onset breast cancer in BRCA1 and BRCA2 mutation carriers
por: Evans, DG, et al.
Publicado: (2017)

Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia
por: Wen, Wei Xiong, et al.
Publicado: (2018)

A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilot
por: Torr, Bethany, et al.
Publicado: (2022)

Identification of Novel BRCA1 and RAD50 Mutations Associated With Breast Cancer Predisposition in Tunisian Patients
por: Mighri, Najah, et al.
Publicado: (2020)

Epithelial ovarian cancer risk: A review of the current genetic landscape
por: Flaum, Nicola, et al.
Publicado: (2019)

Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort
por: Stoltze, Ulrik Kristoffer, et al.
Publicado: (2023)

BRCA1 Circos: a visualisation resource for functional analysis of missense variants
por: Jhuraney, Ankita, et al.
Publicado: (2015)

Role of BRCA gene dysfunction in breast and ovarian cancer predisposition
por: Scully, Ralph
Publicado: (2000)

Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap
por: McCuaig, Jeanna M, et al.
Publicado: (2018)

Perspectives on the implications of carrying putative pathogenic variants in the medulloblastoma predisposition genes ELP1 and GPR161
por: Smith, Miriam J, et al.
Publicado: (2023)

Whole‐exome sequencing of ovarian cancer families uncovers putative predisposition genes
por: Zhu, Qianqian, et al.
Publicado: (2019)

Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome
por: Schneider, Nayê Balzan, et al.
Publicado: (2018)

Germline variation in BRCA1/2 is highly ethnic‐specific: Evidence from over 30,000 Chinese hereditary breast and ovarian cancer patients
por: Bhaskaran, Shanmuga Priya, et al.
Publicado: (2019)

MSH6 germline mutations in early-onset colorectal cancer patients without family history of the disease
por: Pinto, C, et al.
Publicado: (2006)

Ethnic‐specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population
por: Qin, Zixin, et al.
Publicado: (2022)

Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women
por: Sidon, L, et al.
Publicado: (2012)

Genetic Predisposition to Infectious Disease
por: Klebanov, Nikolai
Publicado: (2018)

Sensitivity and specificity of loss of heterozygosity analysis for the classification of rare germline variants in BRCA1/2: results of the observational AGO-TR1 study (NCT02222883)
por: Hauke, Jan, et al.
Publicado: (2022)

Germline truncating-mutations in BRCA1 and MSH6 in a patient with early onset endometrial cancer
por: Kast, Karin, et al.
Publicado: (2012)

Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer
por: Nicolussi, Arianna, et al.
Publicado: (2019)

Tumour risks and genotype–phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD
por: Andrews, Katrina A, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fbp61kuoqrksjhm1eib0hc4h40